|
Vogelsang, G B; Hess, A D (1994) Graft-versus-host disease: new directions for a persistent problem. Blood 84:2061-7
|
|
Horn, T D; Bauer, D J; Vogelsang, G B et al. (1994) Reappraisal of histologic features of the acute cutaneous graft-versus-host reaction based on an allogeneic rodent model. J Invest Dermatol 103:206-10
|
|
Krenn, M; Gamcsik, M P; Vogelsang, G B et al. (1992) Improvements in solubility and stability of thalidomide upon complexation with hydroxypropyl-beta-cyclodextrin. J Pharm Sci 81:685-9
|
|
Vogelsang, G B; Farmer, E R; Hess, A D et al. (1992) Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med 326:1055-8
|
|
Tamura, F; Vogelsang, G B; Reitz, B A et al. (1990) Combination thalidomide and cyclosporine for cardiac allograft rejection. Comparison with combination methylprednisolone and cyclosporine. Transplantation 49:20-5
|
|
Vogelsang, G B (1990) Acute graft-versus-host disease. Cancer Treat Res 50:55-77
|
|
Vogelsang, G B; Wagner, J E (1990) Graft-versus-host disease. Hematol Oncol Clin North Am 4:625-39
|
|
Chen, T L; Vogelsang, G B; Petty, B G et al. (1989) Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers. Drug Metab Dispos 17:402-5
|
|
Vogelsang, G B; Hess, A D; Friedman, K J et al. (1989) Therapy of chronic graft-v-host disease in a rat model. Blood 74:507-11
|
|
Vogelsang, G B; Wells, M C; Santos, G W et al. (1988) Combination low-dose thalidomide and cyclosporine prophylaxis for acute graft-versus-host disease in a rat mismatched model. Transplant Proc 20:226-8
|
Showing the most recent 10 out of 12 publications
